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Abstract Recent studies have identified novel lymphocyte
subsets named innate lymphoid cells (ILCs) lacking antigen-
specific receptors. ILCs are present in a wide variety of
epithelial compartments and occupy an intermediate position
between acquired immune cells and myeloid cells. ILCs are
now classified into three groups: group 1 ILC, group 2 ILC,
and group 3 ILC based on their cytokine production patterns
that correspond to the helper T cell subsets Th1, Th2, and
Th17, respectively. ILCs play important roles in protection
against various invading microbes including multicellular par-
asites, and in the maintenance of homeostasis and repair of
epithelial layers. Excessive activation of ILCs, however, leads
to various inflammatory disease conditions. ILCs have thus
attracted interests of many researchers in the fields of infec-
tious immunity, inflammatory diseases, and allergic diseases.
Because epithelial cells sense alterations in environmental
cues, it is important to understand the functional interaction
between epithelial cells, ILCs, and environmental factors such
as commensal microbiota. We discuss in this review develop-
mental pathways of ILCs, their functions, and contribution of
commensal microbiota to the differentiation and function of
ILCs.
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Immune cells in innate immunity
Immune cells are divided into two categories, acquired im-
mune cells and innate immune cells, based on their ability to
recognize specific antigens. T cells and B cells recognize
specific antigens by their unique antigen receptors, which
are wholly dependent on recombination-activating genes
(Rag1 and Rag2) for the acquisition of antigen specificities.
Innate immune cells do not have specific antigen receptors
and can be divided into two types, myeloid cells and innate
lymphoid cells (ILCs). Although there is no clear definition
for the myeloid and lymphoid classifications, it is believed
that small and round cells with a high nucleus/cytoplasm ratio
are lymphoid cells. The development of myeloid cells is
dependent on PU.1, a member of the Ets family of transcrip-
tion factors. PU.1 is not specific to myeloid cell development,
however, since B cells are absent in PU.1-deficient mice [1].
Myeloid cells express pattern recognition receptors (PRRs)
such as Toll-like receptors (TLRs) and C-type lectin receptors
(CLRs) on their cell surface and recognize molecular struc-
tures on microbes. The major roles of these cells are phago-
cytosis to kill invading microbes and antigen processing to
present antigens to acquired immune cells. ILCs, which are
morphologically similar to T and B cells, occupy an interme-
diate position between acquired immune cells and myeloid
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cells. The helix-loop-helix transcription factor inhibitor of
DNA binding 2 (Id2) and cytokine signaling through cytokine
receptor common gamma chain (γc) are required for the
development of all ILCs. While acquired immune cells and
myeloid cells work cooperatively, ILCs respond directly to
cytokines from both myeloid cells and non-immune cells such
as epithelial cells and play crucial roles in the protection of
epithelial barriers against infections, repair of epithelial integ-
rity, and maintenance of organ homeostasis.
Natural killer (NK) cells have long been an orphan innate
lymphocyte population because they have been considered a
member of lymphocytes but lack antigen receptors. In the late
1990s, another type of lymphocyte-lacking antigen receptors
was found in fetal tissues. These cells play crucial roles in the
differentiation of lymphoid organs such as lymph nodes and
Peyer’s patches and were named lymphoid tissue inducer
(LTi) cells. During the last several years, new members of
the ILC family have been reported frommany laboratories and
studies on ILCs are on the rise, resulting in reports of various
ILCs in many tissues with different proposed names. To
clarify the identities of ILCs and classify ILCs based on their
functions, a panel of researchers within this field introduced a
system for the classification and naming of ILCs and reported
their proposal in Nature Reviews Immunology in 2013 [2]. In
this review article, ILCs were divided into three groups: group
1 ILC (ILC1 and NK cells), group 2 ILC (ILC2s), and group 3
ILC (ILC3s and LTi) based on their cytokine production
patterns that correspond to the helper T cell subsets Th1,
Th2, and Th17, respectively. This classification has been
generally accepted by researchers in this field, but as devel-
opmental pathways and functions of ILC subsets continue to
be extensively studied, we faced some incongruities with
these descriptions. For example, classical or conventional
NK (cNK) cells that are classified as group 1 ILC seem to
have distinct developmental pathways to other cell types
within this group. Similarly, LTi cells appear to depend on
different transcription factors for their differentiation among
group 3 ILCs. ILC1, ILC2s, and ILC3s are all dependent on a
transcription factor promyelocytic leukemia zinc finger
(PLZF), but differentiation of cNK cells and LTi cells is
independent of PLZF.
Common and distinct differentiation pathways of ILCs
All lymphocytes are derived from common lymphoid progen-
itors (CLP) in the fetal liver and adult bone marrow and are
characterized by the lineage (Lin)−c-KitintSca-1+IL-7Rα+
phenotype. Knockout studies have identified the transcription
factor Id2 and cytokine signals mediated by γc as essential
factors for the development of all ILCs. T and B cells develop
independent of Id2 but require Rag1 and Rag2 genes for
recombination of their antigen receptors. On the other hand,
Rag1 and Rag2 genes are dispensable for differentiation of
ILCs. Interestingly, Yang et al. showed by fate mapping
analysis that a fraction of ILC2s once expressed Rag2, dem-
onstrating the close relationship between antigen receptor-
expressing lymphocytes and ILCs [3]. It was later shown that
Gata3 is critical for the differentiation of ILC1, ILC2s, ILC3s,
and LTi but not for cNK cells. Klose et al. recently reported the
existence of a Lin−Id2+IL-7Rα+CD25−α4β7+Flt3− progeni-
tor population that they named common helper-like innate
lymphoid cell progenitor (CHILP) capable of developing into
all ILC subsets except cytotoxic cNK cells, indicating that
cNK cells are distinct from other ILCs [4]. E4BP4 or NF-IL3
was originally reported as an essential transcription factor for
cNK cell differentiation, but it was later shown that the lack of
E4BP4 impairs the differentiation of all ILCs by the reduction
of CHILP, indicating that E4BP4 also controls the differenti-
ation of all ILCs, not only that of cNK cells. In addition,
Constantinides et al. found that PLZF, which has been known
to control differentiation of innate-type CD1d-restricted NKT
cells [5, 6], is transiently expressed in CHILP during ILC
differentiation. Fate mapping studies for the expression of
Zbtb16, the gene encoding PLZF, showed labeling of ILC1,
ILC2s, and ILC3s but not cNK cells and LTi cells [7]. Con-
sistent with this observation, Zbtb16-deficient mice showed
normal development of cNK cells and LTi cells whereas
differentiation of ILC1, ILC2s, and ILC3s were variously
affected. Accordingly, PLZF+ CHILP differentiates to ILC1,
ILC2s, and ILC3s but not to cNK cells or LTi cells based on
adoptive transfer experiments and clonal differentiation assays
[7]. These recent results collectively showed that cNK cells
branch out fromCLP prior to differentiation of CLP to CHILP,
followed by branching out of LTi before acquisition of PLZF
expression by CHILP. Lineage specification of ILC1, ILC2s,
and ILC3s from PLZF+ CHILP takes place by acquisition of
T-bet, Gata3, and RORγt expression, respectively (Fig. 1a).
Group 1 ILC
Studies on group 1 ILC began with the discovery of cNK cells
that exhibit cytotoxic activity against tumor cells [8, 9]. Unlike
cytotoxic T lymphocytes (CTLs), NK cells lack T cell recep-
tors to recognize complexes of antigen-derived peptides and
major histocompatibility complex (MHC). Instead, NK cells
utilize CLRs to recognize various molecules expressed on
target cells that are mostly induced by cellular stresses such
as viral infection. NK cells also recognize self MHC mole-
cules by a unique set of receptors acting as inhibitory receptors
to suppress activation signals. Target cells of self-origin can be
killed by NK cells when self MHC molecules are downregu-
lated. This can often be observed in tumor cells and in infec-
tion by herpes viruses or when self MHC molecules are
heavily modified by viral infection. It is also known that NK
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cells are potent producers of IFNγ upon activation. Further-
more, NK cells produce IFNγ in response to IL-12 derived
from myeloid cells such as macrophages and dendritic cells,
and IL-18 further enhances IFNγ production by NK cells. NK
cells thus have dual functions, namely cytotoxicity and cyto-
kine production (Fig. 2).
NK cells express Tbx21 (T-bet), critical for IFNγ expres-
sion, and secrete granules containing granzyme B and
perforin, both of which induce apoptosis of target cells such
as cancer cells and cells infected with intracellular microbes.
Among γc cytokines, IL-15 is essential for the differentiation
of cNK cells, and unlike other ILCs, IL-7 is dispensable for
cNK differentiation [8]. In 2006, DiSanto and colleagues
identified thymic NK cells that show less cytotoxic activity
than cNK cells but express higher amounts of IFNγ than cNK
cells [10]. It was intriguing at that time that differentiation of
thymic NK cells was dependent on IL-7 and Gata3 but inde-
pendent of IL-15, raising the possibility that there are at least
two distinct lineages for NK cells. An NK-like population that
expresses T-bet and produces IFNγ in response to IL-12 but
expresses low levels of granzyme B and perforin was later
reported, and this population was termed ILC1 [11]. ILC1 are
present in mucosal tissues and share functional features with
tissue-resident memory CD8 T cells that require T-bet and
E4BP4 for their development and contribute to the pathophys-
iology of IBD [12]. While cytotoxic cNK cells express
Fig. 1 Developmental pathways
of ILCs. All ILCs require Id2
signaling for their development.
cNK cells branch out earlier than
other helper-like ILCs and LTi
cells branch out from CHILP. Cell
fate determination processes of
ILC, ILC2s, and ILC3s from
PLZF+ ILCP are still unknown,
but there are two possibilities: a
determined after PLZF+ ILCP or
b cell fate determinations are
already established before or at
the PLZF+ ILCP stage
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perforin, granzyme B, CD56, CD16, CD94, and NKp46,
ILC1 are negative for these markers and express, CD161
and CD69, suggesting the presence of at least two phenotyp-
ically and functionally distinct populations among group 1
ILCs [11, 12] (Fig. 2).
As mentioned above, Klose et al. recently reported the
existence of a Lin−Id2+IL-7Rα+CD25−α4β7+Flt3− CHILP
capable of developing into all ILC subsets except cNK cells,
indicating that cytotoxic cNK cells are distinct from other
helper- l ike ILCs [4] . Fur thermore, Lin− Id2+IL-
7Rα+CD25−α4β7+Flt3− progenitor cells are able to differen-
tiate into an NKp46+IL-7Rα+ ILC lineage, which have strong
helper function due to IFNγ production and are called ILC1.
Both cytotoxic NK cells and ILC1 constitutively express T-bet
but differ in the cytokines required for their development.
cNK cells depend on IL-15 but not IL-7 [13] while all other
ILCs depend on IL-7 but not IL-15. It has been reported that
early pre-pro NK cells and immature NK cells express high
levels of IL-7Rα [14], but the IL-7 requirement for ILC1 is
less well understood. Taken together, these results clearly
define two developmentally distinct group 1 ILCs leading
researchers within the field to refer to cytotoxic NK cells as
cNK cells and to use the term “ILC1” to refer to Lin−Id2+IL-
7Rα+CD25−α4β7+Flt3− derived non-cytotoxic IFNγ-pro-
ducing cells that have helper functions (Fig. 1). The name
“group 1 ILC” is the all-inclusive term for conventional NK
cells and ILC1. Moreover, the evidence suggests that the term
ILC1 is likely not a suitable abbreviation for “group 1 ILC”.
Microbiota are considered to be a critical factor for lym-
phoid organogenesis, maintenance of epithelial homeostasis,
and development of acquired immune cells. Unlike acquired
immune cells, cNK cells do not require commensal bacteria
for their development [15]. There are indeed no differences in
the expression of KLRG1, CD122, CD49b, NKG2D, and
NKp46 on cNK cells between specific-pathogen-free (SPF)
and germ-free (GF) housed mice. However, it has been dem-
onstrated that expression of granzyme B and IFNγ were
significantly suppressed in GF mice as a result of lack of
priming signals that mostly depend on dendritic cells (DCs).
Although contribution of commensal bacteria to ILC1 differ-
entiation and function is not well understood, a critical rela-
tionship via epithelial cells likely exists between commensal
bacteria and ILC1.
Group 2 ILC
We started our work on group 2 ILC based on our finding of
previously unidentified lymphoid clusters in adipose tissue,
which we termed fat-associated lymphoid cluster (FALC)
[16]. During the process of cellular analysis of FALC, we
found a unique population of cells that express c-Kit and
Sca-1 but not lineage markers. Up until that point, cells with
the Lin−c-Kit+Sca-1+ phenotype were called LSK, a cell pop-
ulation that contains hematopoietic stem cells and progenitor
cells capable of differentiating into a variety of immune cell
types. However, FALC Lin−c-Kit+Sca-1+ cells did not exhibit
any developmental potential to other types of cells either
in vivo or in vitro, suggesting that these cells are different
from typical LSK cells. High expression of Th2-related genes
in FALC Lin−c-Kit+Sca-1+ cells revealed from microarray
analysis led us to reconsider the identity of this population:
these cells are mature cells but not progenitor cells. A unique
characteristic of this population was their ability to constitu-
tively produce type 2 cytokines including IL-5, IL-6, and IL-
13. Indeed, FALC Lin−c-Kit+Sca-1+ cells were able to support
cell division of B1 B cells in a simple co-culture system,
through IL-5 that is constitutively produced by this popula-
tion. Furthermore, co-cultivation of FALC Lin−c-Kit+Sca-1+
cells with splenic B cells resulted in the production of IgA,
demonstrating the helper function of FALC Lin−c-Kit+Sca-1+
cells. Type 2 cytokines are known to be important in anti-
helminth immunity, and it was well known that IL-5 and IL-13


















Fig. 2 Role of group 1 ILCs.
Bacteria captured by dendritic
cells (DC) induce IL-12
production to stimulate both
conventional NK cells (cNK) and
ILC1, both of which produce
IFN-γ and accelerate macrophage
phagocytosis. cNK cells exhibit
cytotoxic activity by
degranulating granzyme and
perforin and induce apoptosis of
target cells such as infected
epithelial cells
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helminth-specific adaptive Th2 response is established, dem-
onstrating the presence of type 2 innate immune responses
against helminth infection. We therefore wondered if FALC
Lin−c-Kit+Sca-1+ cells are involved in the innate immune
response against helminth infection. To demonstrate the role
of FALC Lin−c-Kit+Sca-1+ cells in anti-helminth immunity,
we focused on two previous reports demonstrating strong type
2 immune responses triggered by IL-25 and IL-33 [17, 18].
We subsequently found that IL-33 and a combination of IL-2
plus IL-25 can induce production of large quantities of type 2
cytokines such as IL-5 and IL-13 in FALC Lin−c-Kit+Sca-1+
cells. Furthermore, we demonstrated that these cells contribute
to protection against helminth infection mediated by eosino-
philia and goblet cell hyperplasia. Therefore, we termed
Lin−c-Kit+Sca-1+ cells natural helper (NH) cells based on their
helper functions to both immune and non-immune cells [16].
A similar cell type, termed nuocytes, was later reported
using GFP reporter mice in which GFP was inserted into the
coding region of Il13 gene [19]. Nuocytes were defined as
GFP+ cells upon administration of IL-25 or IL-33, but a
corresponding population in naïve mice was obscure.
Nuocytes are slightly different from NH cells because they
are induced in the lymph node or spleen following IL-25
injection and express MHC class II but not CD25, unlike
NH cells. However, the role of nuocytes is similar to that of
NH cells in that they are also important in anti-helminth
immunity. It is currently unclear whether NH cells and
nuocytes are derived from the same lineage, and the possibil-
ity exists that nuocytes are IL-25-activated NH cells. Both cell
types are current members of group 2 ILC. It is confusing that
while ILC1 is a subset of group 1 ILCs, the term ILC2 is used
as an abbreviated term for group 2 ILC. To clarify the distinc-
tion between subset name and group name, we recommend
that group 2 ILC be called ILC2s. Following reports on the
discovery of ILCs, there were a series of reports demonstrat-
ing the role of ILC2s in mice and humans [20–31]. ILC2s are
localized not only in adipose tissues and lymphoid organs but
also in other peripheral tissues including liver, lung, intestine,
bone marrow, body cavity, dermis, and peripheral blood [23,
29, 31–35]. ILC2s are involved in anti-helminth innate immu-
nity as well as in other conditions including, but not limited to
asthma, atopic dermatitis, cancer, and hepatic fibrosis. Re-
search toward understanding the role of ILC2s in asthma has
been extensively performed. Strong type 2 cytokine produc-
tion by ILC2s that results in eosinophilia and goblet cell
hyperplasia is critical for the expulsion of worms during
helminth infection (Fig. 3). However, induction of eosinophil-
ia and goblet cell hyperplasia is also known to exacerbate
symptoms in various allergic diseases such as asthma.
Neutrophil-dominant asthma was once thought to be much
more severe than eosinophil-dominant asthma, but the oppo-
site is now considered to be true [36]. In clinical practices, the
greatest difficulty encountered during asthma treatment is
corticosteroid resistance, which is found in 5 to 10 %
of asthma patients. ILC2s are involved in the develop-
ment of corticosteroid resistance through co-stimulation
by IL-33 and thymic stromal lymphopoietin (TSLP), the
latter of which strongly activates STAT5 and inhibits
apoptosis of ILC2s [32]. While ILC2s exacerbate the
severity of symptoms in asthma, amphiregulin produced
by ILC2s during influenza virus infection has been shown to
be important in the repair of wounded tissue, indicating that
ILC2s are involved in the induction of the eosinophilic in-
flammatory response and tissue repair after inflammation [37]
(Fig. 3).
Id2 [16], RORα [38], TCF-1 [39], GATA3 [33, 40, 41, 34],
Gfi1 [42], and E4BP4 [43, 44] are transcription factors that are
involved in the differentiation of ILC2s, and IL-7 [16] and
notch signaling [38] are requisite external factors. While de-
fects in Id2, GATA3, and IL-7 completely impair the differ-
entiation of ILC2s, the absence of RORα, TCF-1, Gfi1, and
E4BP4 resulted in a marked reduction in the number of ILC2s.
Interestingly, loss of Gfi1 resulted in inhibition of IL-33 but
not IL-25-dependent expansion of ILC2s in the lung and
MLN [42]. Among the above transcription factors, RORα
appears to be the only transcription factor that specifically
regulates differentiation of ILC2s but not other ILCs. RORα
is highly expressed in ILC2s [16], and its deficiency greatly
reduced the number of ILC2s [38, 45]. Interestingly, a small
number of ILC2 cells are present in the mesentery of Rorαstg
mice, a natural mutant mouse lacking functional RORα, and
these ILC2 cells produced normal amounts of IL5 and IL-13
in response to IL-33, indicating that RORα is involved in the
differentiation of ILC2s but dispensable for cytokine gene
expression [34]. In contrast, deletion of Gata3 in mature
ILC2 cells resulted in impaired production of IL-5 and IL-13
without affecting IL-6 production [34]. GATA3 binds to the
promoter/enhancer region of Il5 and Il13 gens in ILC2 cells,
and the deletion of Cgre encoding a GATA3-binding site
within the Il13 promoter specifically impaired the expression
of IL-13 [34]. GATA3, TCF-1, and Gfi1 but not RORα are
important factors for type 2 cytokine production.
The progenitor of ILC2s was first proposed by Yang et al.,
demonstrating that ILC2s are CLP-derived cells [3]. Fate
mapping analysis of Rag2 expression showed that a fraction
of ILC2s once expressed Rag2. Subsequently, two types of
ILC committed progenitors were described in fetal liver and
bone marrow, Lin−PLZFhighIL-7Rα+c-Kit+α4β7high cells and
Lin−Id2+IL-7Rα+CD25−α4β7+ Flt3−cells [7, 4] (Fig. 1). The
relationship between these two progenitors has not been elu-
cidated. A Lin−Sca-1hiId2hiGATA3hi cell (ILC2P) population
in the bone marrow was reported to be an ILC2 specific
progenitor, but this population has already acquired the ability
to produce type 2 cytokines, indicating that the ILC2P popu-
lation is likely immature ILC2s but not ILC2 progenitors [33].
The theory for the existence of immature ILC2s is backed by
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data that lack of Gfi1 resulted in the loss of ILC2P but not
mature ILC2s in the lung and MLN [42].
There are currently no reports of a relationship between
microbiota and ILC2s, and it is known that commensal bac-
teria are not required for the development of ILC2s since the
number of ILC2s does not differ between germ-free and SPF
mice [37]. TSLPwhich accelerates type 2 cytokine production
by ILC2s is induced by commensal bacteria in the colon [46],
however, suggesting that microbiota may play an important
role in the function of ILC2s.
Group3 ILC
In 1992, Kelly and Scollay reported on a novel cell subset
expressing CD4 but not CD3 in neonatal LN cells [47]. The
function of this population was unclear until two research
groups identified novel subsets in 1997, which were later
called LTi cells: CD4+CD3−LTβ+ cells that express α4β7
and are involved in the formation of lymph nodes [48] and
IL-7R+ cells that induce formation of Peyer’s patches [49, 48].
During late fetal life, LTi cells produce LTα and LTβ in
response to IL-7 or RANKL [50] stimulation and induce
VCAM-1 [49, 51] and MAdCAM-1 [52] expression on lym-
phoid tissue organizer (LTo) cells that will later develop into
LN or Peyer’s patch anlagen (Fig. 4). Entry of T cells and B
cells into the lymphoid anlagen to complete maturation of
lymphoid tissues depends on chemokines such as CXCL13,
CCL19, or CCL21 from LTo cells and is a final step of
lymphocerastism. Retinoic acid-related orphan receptor γt
(RORγt) was demonstrated to be an essential factor for the
development of LTi cells, and lack of RORγt resulted in
hypoplastic defects of lymph nodes and PP but not spleen,
suggesting that LTi cells are involved in the formation of
lymph nodes and Peyer’s patches but not spleen [53]. It is
currently well-known that LTi cells are not fetal-specific cells
but remain in adult tissues, and are involved in the formation
of secondary lymphoid tissues such as isolated lymphoid
follicles (ILF) in the intestine.
During the middle of a surge in Th17 research in the mid-
2000’s, Takatori et al. identified CD4+CD3− LTi-like cells, an
innate source of IL-17 and IL-22, which express IL-23 recep-
tor, aryl hydrocarbon receptor (AHR) and CCR6, indicating
that LTi cells are not only important for the formation of
secondary lymphoid tissues but also for host defense by type
3 cytokine production [54]. Around the same time, Satoh-
Takayama et al. also reported on a unique population that
expresses NKp46 (NCR) in the small intestine [55] and is
clearly different from conventional NK cells due to the lack of
perforin and limited IFNγ expression. NKp46+ cells express
RORγt and produce sufficient amounts of IL-22 for protec-
tion against Citrobacter rodentium infection. A similar subset
of cells that produce IL-22 and IL-26 following IL-23 expo-
sure in mucosa-associated lymphoid tissues such as tonsils
and Peyer’s patches was characterized in a human study [56].
Collectively, these three reports suggested the presence of a
unique population, which is phenotypically similar to LTi
cells, but has a different cytokine profile and plays a role in
microbial infection (Fig. 4).
LTi cells and IL-22 producing cells are collectively termed
group 3 ILC based on the requirement for RORγt for their
development. While CCR6+ LTi cells are called LTi cells,
CCR6− cells are generally termed ILC3s. CCR6 is an impor-






















Fig. 3 Role of group 2 ILCs. In steady state conditions, ILC2s support
the maintenance of IgA secretion from B cells in the intestine and B1 cell
survival in the peritoneal cavity. During helminth infection, epithelial
cells produce IL-25 and IL-33 to activate ILC2s, and both cytokines
induce IL-5, eotaxin and IL-13 production by ILC2s. IL-5 and eotaxin
are important for the expansion and migration of eosinophils, and IL-13
induces goblet cell hyperplasia and mucin production. Eosinophils
degranulate enzymes such as major basic protein (MBP) to attack the
worm, and mucin produced by goblet cells rinses out the worm from the
intestinal lumen. IL-33 also stimulates basophils in the early phase of
infection to produce IL-4, which induces the initial IL-5 and IL-13
production by ILC2s
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cryptopatches by LTi cells after birth. ILC3s can be divided
into two subpopulations based on NKp46 expression.
NKp46+ ILC3, once called ILC22, are exclusively localized
in the intestinal lamina propria in the mouse, and a similar
population has been reported in human tonsils [57]. NKp46+
ILC3s do not produce IL-17 in response to IL-23, but produce
IL-22 and function in protection against microbial infection
and in tissue homeostasis and repair. On the other hand,
NKp46− ILC3, which were previously called ILC17, and
LTi cells, produce both IL-17 and IL-22 upon IL-23 stimula-
tion. Furthermore, NKp46+ ILC3s require T-bet for their
development whereas LTi cells develop independently of T-
bet [58]. LTi cells can be divided into two subpopulations
based on CD4 expression, but the difference between these
subpopulations is not clear because both cells produce similar
amounts of IL-22 and IL-17 and express LTα1β2. Similar to
cNK cells in group 1 ILC, LTi cells were unique in group 3
ILC, based on their specialized effects on lymphocerastism.
As mentioned, identification of a PLZFhigh precursor clearly
demonstrated that NK cells and LTi cells are distinct popula-
tions from ILC1, ILC2s, and ILC3s [7]. Although the posi-
t ional relationship between two ILC progenitors
Lin−PLZFhighIL-7Rα+c-Kit+α4β7high cells termed ILCP and
Lin−Id2+IL-7Rα+CD25−α4β7+ Flt3−cells termed CHILP for
helper-like ILCs [4] remains unclear, ILCP seem to be a more
specific progenitor of the ILCs, because CHILP has been
reported to be heterogeneous for expression of PLZF. More-
over, the possibility remains that ILCPs are a composite of the
earliest progenitors of ILC1, ILC2s, and ILC3s, based on the
result of PLZFhigh single cell culture. PLZFhigh cells from fetal
liver were co-cultured on OP9 stromal cells for 5–6 days, and
development was assessed by flow cytometry analysis. As a
result, 7 out of 500 wells developed into all three lineages,
while 51 wells developed into double lineage (ILC1,2 :
ILC2,3 : ILC3,1=9 : 21 : 21 ) and all other wells differentiated
into single ILC (ILC1 : ILC2 : ILC3=230 : 141 : 71) [7]. It is
possible that the PLZFhigh cell fraction is a mixture of com-
mitted progenitors of ILC1, ILC2s, and ILC3s.
There is increasing evidence for crosstalk between com-
mensal microbiota and group 3 ILC. It was controversial
whether commensal bacteria are essential for the development
of group3 ILC3. While some groups reported the importance
of commensal microbiota for the development of NKp46+
ILC3 [59, 55], others demonstrated commensal microbiota-
independent development of RORγt+ ILC3 [60, 61], and
Reynders et al. reported normal development and increased
IL-22 production of NKp46+RORγt+ ILC3 in the small intes-
tine of germ-free mice [62]. Recent report has shown that
NKp46 expression is downstream of T-bet that is induced by
microbiota and thus NKp46+T-bet+ ILC3s are mostly depen-
dent on microbiota [63]. In addition, CCR6− ILC3s are de-
pendent upon the microbiota, while TLi cells are largely
independent of the microbiota [63]. Because it is difficult to
discern whether environmental factors including commensal
bacteria are involved in the differentiation, mechanisms how
microbiota regulates the homeostasis of ILC3s remain to be
elucidated.
Infection with Salmonella and Pseudomonas species in-
duces IL-1β production by intestinal mononuclear phagocytes
through the NLRC4 inflammasome pathway, which is critical
for the upregulation of endothelial adhesion molecules and
































Fig. 4 Role of group 3 ILCs. In response to IL-23 produced by dendritic
cells (DC), NKp46−ILC3s produce IL-17 for the activation of neutrophil
migration and protection against bacteria through antibiotic peptide
secretion by epithelial cells. NKp46+ILC3s produce IL-22 for tissue
repair. CCR6+ LTi cells in the isolated lymphoid follicles (ILF) interact
with stromal cells via lymphotoxin (LT) and LT receptor to enhance
chemokine production for lymphocerastism. Macrophages produce IL-
1β to induce GM-CSF by both LTi cells andNKp46+ILC3s, which seems
to be important for the induction of oral tolerance
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et al. reported that ILC3s in the isolated lymphoid follicles
produce GM-CSF to promote oral tolerance in response to IL-
1β from intestinal macrophages [65]. They demonstrated that
LTi cells and NKp46+ ILC3s but not NKp46+RORγt− NK
cells produce GM-CSF in steady-state conditions. GM-CSF
production was absent in newborn mice, and strongly reduced
by treatment with broad-spectrum antibiotics in both the small
and large intestine in adult mice, suggesting that commensal
bacteria are essential for this production (Fig. 4). ILC3s also
play a role in epithelial cell fucosylation, which is important
for the integrity of epithelial cells and protection against
bacterial infection [66], indicating that both ILC2s and ILC3s
are important in the maintenance of epithelial integrity.
AHR seems to play a role in ILC3 differentiation and
function. Ahr-deficient mice exhibited normal development
of CCR6+ LTi cells but reduced numbers of CCR6− ILC3 cells
[67, 61, 63, 68]. Consistent with these observations, lymph
nodes and Peyer’s patches that are formed during fetal stages
are mostly normal in Ahr-deficient mice, whereas
cryptopatches and ILF are absent in the absence of Ahr ex-
pression. Although the mechanisms by which AHR controls
ILC3 differentiation are unknown, AHR may regulate genes
involved in the differentiation of ILC3. For example, AHR is
known to bind to the promoter of the c-Kit gene [69]. AHR is
also known to act as a sensor of environmental cues by
sensing various small molecules. AHR binds nutrient-
derived glucobrassicins that are contained in vegetables of
the Brassicaceae family (for example, Broccoli) and drives
postnatal expansion of CCR6− ILC3 and intraepithelial γδ T
cells [69, 70]. It is thus possible that phytochemicals control
the development and maintenance of the immune system at
the intestinal barrier surfaces.
In addition, recent studies have shown the importance of
another nutrient, vitamin A, in the differentiation of ILC3s.
Rarα-deficient mice lacking retinoic acid receptor (RAR)α in
hematopoietic cells have a reduced number of fetal LTi cell
partly because RARα binds the promoter region of the Rorc
gene and upregulates the expression of RORγt. As a result,
adult Rara-deficient mice have smaller lymphoid organs and
are less tolerant to viral infections [71]. Spencer et al. (2014)
reported that deprivation of vitamin A in adult mice resulted in
the reduction of IL-22-producing ILC3 and impaired immu-
nity against C. rodentium [72]. Intriguingly, the number of
ILC2s increased in these mice, demonstrating that the mech-
anisms balancing ILC2 and ILC3 in mucosal barrier surfaces
are nutrient-dependent.
Conclusion and perspectives
We have discussed the differentiation and function of ILCs
and their relationship between environmental factors includ-
ing commensal microbiota. As discussed, ILCs are distributed
throughout the epithelial compartment and are involved in the
maintenance of epithelial integrity and protection against var-
ious invading microbes. Commensal microbiota likely play
important roles in the maintenance of epithelial integrity
through their effects on ILC differentiation and function. It is
well known that environmental factors including commensal
microbiota affect cellular characteristics through epigenetic
modifications. Therefore, it is of interest to consider evidence
for the possible involvement of commensal microbiota in the
plasticity between distinct ILCs. IFN-γ-producing ILC1 that
express the receptor for IL-7 and lack NK cell markers and
lytic enzymes, arise from the conversion of RORγt+ ILC3s
under the influence of IL-12 during inflammation [11]. Sim-
ilarly, RORγt+ IFN-γ-producing cells can be induced from
human ILC3s in vitro by culturing with IL-2 [73–75]. In mice,
fate-mapping experiments showed that some IFN-γ-
producing ILC1 cells are indeed derived from RORγt+ ILC3s
[4, 76]. These studies collectively suggest that a certain frac-
tion of ILC1 might stem from ILC3s. Compared to ILC1 and
ILC3s, ILC2s seem to be a relatively stable subset. However,
it is still possible that there is plasticity between ILC2s and
other ILC subsets [42, 77]. Crellin et al. reported that human
ILC3s can produce IL-5 and IL-13 when stimulated with
TLR2 ligands [77]. In addition, Spooner et al. showed that
lack of the Gfi1 gene resulted in the loss of GATA-3 expres-
sion and coexpression of IL-13 and IL-17 [42]. They showed
that Gfi1 suppresses the phenotypic characteristics of ILC3s
through suppression of the Sox4-Rorc axis that is required for
the expression of the Il17a gene [42]. The mechanisms for the
stabilization of the characteristics of ILCs and those driving
the plasticity between distinct ILCs and involvement of com-
mensal microbiota remain to be elucidated in future studies.
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